Re: Exports to Jordan

28 Sep 2007 07:01

Beximco Pharmaceuticals Ltd28 September 2007 BEXIMCO PHARMACEUTICALS LTD. 28 September 2007 Beximco Pharma Commences Exports to Jordan Beximco Pharmaceuticals Ltd. ("BPL" or the "Company"), the leadingpharmaceutical manufacturer and the largest pharmaceutical exporter ofBangladesh, today announces that it has started supplying its medicine toJordan. Jordan is a strategically located country in the Middle East and is a key memberof the League of Arab Nations & Greater Arab Free Trade Area (GAFTA), one of themost promising trade blocs in the world. The country has a very good reputationin the region for its high standards of healthcare services. The pharmaceuticalmarket of Jordan, valued at approximately $315 million, is heavily dependant onimported medicines with more than 70% medicines are imported from Europe. BPL has received marketing authorization for four products in Jordan and anumber of other products are in the registration pipeline. Mr. Nazmul Hassan, CEO of Beximco Pharma said: "With a market size of around US $8 billion and a growth rate second only toSoutheast Asia and China, the Middle East plays a strategically important partin our global expansion programme. Being a member of GAFTA, and with its welldeveloped infrastructure & a high-standard health care system, Jordan hasalready established itself as a regional hub for health-care services andpharmaceutical trade. I hope that being successful in registering and exportingour products in Jordan will boost BPL's entry into the Middle East markets." For further enquiries please contact: Beximco Pharma Tel: +880 2 861 9151, ext.2080Nazmul Hassan, CEO Financial Dynamics Tel: +44 (0)20 7269 7169John Gilbert Libertas Capital Tel: +44 (0)20 7569 9650Aamir Quraishi/Andrew Hardy About Beximco Pharmaceuticals Limited Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sellsgeneric pharmaceutical formulation products, active pharmaceutical ingredientsand intravenous fluids. The Company also manufactures and markets its ownbranded generics for almost all diseases. The Company also undertakes contractmanufacturing for multinational pharmaceutical companies. The Company operatesfrom a 20 acre site in Dhaka and currently employs over 2,400 staff. The Company's products are sold to retail outlets, medical institutions andother pharmaceutical manufacturers in Bangladesh, in regional markets such asPakistan, Nepal, Bhutan, Cambodia and Myanmar and in other markets overseas,principally in East Africa and South East Asia, including Singapore. This information is provided by RNS The company news service from the London Stock Exchange